Viewing Study NCT06413095

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:21 PM
Ignite Modification Date: 2026-01-05 @ 1:14 AM
Study NCT ID: NCT06413095
Status: COMPLETED
Last Update Posted: 2024-05-14
First Post: 2024-04-01
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: PBI-MST-01 (NCT04541108) Substudy MSD-03: Intratumoral Microdosing of Pembrolizumab Alone and With MK-0482 or MK-4830 in HNSCC or STS
Sponsor: Presage Biosciences
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Head and Neck Squamous Cell Carcinoma View
None Soft Tissue Sarcoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HNSCC View
None head and neck cancer View
None head and neck squamous cell carcinoma View
None STS View
None soft tissue sarcoma View
None intratumoral microdosing View
None microdose injection View
None microdosing View
None in vivo oncology View
None tumor microenvironment View
None multiplexed immunohistochemistry View
None pharmacodynamic biomarkers View
None CIVO View
None master protocol View
None precision oncology View
None spatial biology View